CDKN1B and acute lymphoblastic leukemia: Moreover, SIRT1 KO did not decrease the peripheral blood or bone marrow leukemic burden in mice engrafted with p27-specific ShRNA-expressing T-ALL cells (Fig. 5f-h and S6b).